Cargando…

LI-RADS v2017 for liver nodules: how we read and report

The Liver Imaging Reporting and Data System (LI-RADS) standardizes the interpretation and reporting of imaging examinations in patients at risk for hepatocellular carcinoma (HCC). For focal liver observations it assigns categories (LR-1 to 5, LR-M, LR-TIV), which reflect the relative probability of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schima, Wolfgang, Heiken, Jay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978995/ https://www.ncbi.nlm.nih.gov/pubmed/29690933 http://dx.doi.org/10.1186/s40644-018-0149-5

Ejemplares similares

CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017—Can Things Be Put Together?
por: Caraiani, Cosmin, et al.
Publicado: (2021)

CT/MRI LI-RADS v2017 – review of the guidelines
por: Rosiak, Grzegorz, et al.
Publicado: (2018)

CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2021)

CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners
por: Patella, Francesca, et al.
Publicado: (2018)

Standardizing liver imaging reporting and interpretation: LI-RADS and beyond
por: Rich, Nicole E., et al.
Publicado: (2023)

Liver Imaging Reporting and Data System (LI-RADS) v2018: differential diagnostic value of ADC values for benign and malignant nodules with moderate probability (LR-3)
por: Chen, Xue, et al.
Publicado: (2023)

Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC
por: Wen, Rong, et al.
Publicado: (2023)

Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS
por: Chen, Zhiguang, et al.
Publicado: (2022)

The preliminary application of liver imaging reporting and data system (LI-RADS) with contrast-enhanced ultrasound (CEUS) on small hepatic nodules (≤ 2cm)
por: Ling, Wenwu, et al.
Publicado: (2018)

Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning
por: Fotouhi, Maryam, et al.
Publicado: (2023)

Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)
por: Ding, Ying, et al.
Publicado: (2018)

Identification of the origin of tumor in vein: comparison between CEUS LI-RADS v2017 and v2016 for patients at high risk
por: Tong, Wen-juan, et al.
Publicado: (2022)

Liver and pancreas
por: Heiken, Jay P
Publicado: (2015)

Interrater reliability and agreement of the liver imaging reporting and data system (LI-RADS) v2018 for the evaluation of hepatic lesions
por: Abdelrahman, Ahmed S., et al.
Publicado: (2022)

Comparison of LI-RADS v.2017 and ESGAR Guidelines Imaging Criteria in HCC Diagnosis Using MRI with Hepatobiliary Contrast Agents
por: Rosiak, Grzegorz, et al.
Publicado: (2018)

Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver
por: Wang, Peihua, et al.
Publicado: (2021)

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
por: Kim, Tae Kyoung, et al.
Publicado: (2017)

Distinguishing benign from malignant liver tumours
por: Heiken, Jay P.
Publicado: (2007)

A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls
por: De Muzio, Federica, et al.
Publicado: (2022)

Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm
por: An, Chansik, et al.
Publicado: (2016)

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
por: Huang, Zhe, et al.
Publicado: (2023)

Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
por: Zhang, Tong, et al.
Publicado: (2019)

Prostate MRI based on PI-RADS version 2: how we review and report
por: Steiger, Philipp, et al.
Publicado: (2016)

CEUS LI-RADS: a pictorial review
por: Bartolotta, Tommaso Vincenzo, et al.
Publicado: (2020)

The value of the apparent diffusion coefficient value in the Liver Imaging Reporting and Data System (LI-RADS) version 2018
por: Saleh, Gehad Ahmad, et al.
Publicado: (2022)

Incidental findings in the oncology patient: liver
por: Schima, Wolfgang
Publicado: (2014)

Differentiation between combined hepatocellular cholangiocarcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017
por: Li, Chao-qun, et al.
Publicado: (2022)

The do’s and dont’s of liver CT and MR imaging
por: Schima, Wolfgang
Publicado: (2014)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
por: Hu, Yi-Xin, et al.
Publicado: (2021)

Dynamic contrast enhanced CT in nodule characterization: How we review and report
por: Qureshi, Nagmi R., et al.
Publicado: (2016)

Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI
por: Liu, Xinai, et al.
Publicado: (2022)

LI-RADS ancillary features on contrast-enhanced ultrasonography
por: Dietrich, Christoph F., et al.
Publicado: (2020)

Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI
por: Li, Yubo, et al.
Publicado: (2023)

Correction to: Differentiation between combined hepatocellular cholangiocarcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017
por: Li, Chao-qun, et al.
Publicado: (2022)

Differentiation of small (≤ 3 cm) hepatocellular carcinomas from benign nodules in cirrhotic liver: the added additive value of MRI-based radiomics analysis to LI-RADS version 2018 algorithm
por: Zhong, Xi, et al.
Publicado: (2021)

Explainable Automated TI-RADS Evaluation of Thyroid Nodules
por: Kunapinun, Alisa, et al.
Publicado: (2023)

Automated CT LI-RADS v2018 scoring of liver observations using machine learning: A multivendor, multicentre retrospective study
por: Mulé, Sébastien, et al.
Publicado: (2023)

How We Read Oncologic FDG PET/CT
por: Hofman, Michael S., et al.
Publicado: (2016)

PI-RADS v2.1: What has changed and how to report
por: Scott, Robin, et al.
Publicado: (2021)

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance
por: Elsayes, Khaled M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4b9moepo46avl5jn0te0835ag4